Two Directors at Kellanova Co sold 87,600 shares at between 60.052USD and 60.923USD. The significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the las...
Moody's Ratings (Moody's) assigned a Baa2 rating to the new senior unsecured notes issuance of CVS Health Corporation ("CVS"). There are no changes to CVS's existing ratings including the Baa2 senior unsecured long-term rating or the Prime-2 commercial paper rating. The outlook remains unchanged at ...
Arbutus to Participate in Two Upcoming Investor Conferences WARMINSTER, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic hepatitis B virus (cHBV) infection, today announced that the Arbutus management team will participate in and host one-on-one meetings at the following two upcoming investor conferences which are being held in New York: The Citizens JMP Life Sciences Conference: Fireside Chat on May 14, 2024 at...
Moody's Ratings (Moody's) today assigned a Baa2 rating to Kellanova's proposed €300 million of 10-year senior unsecured notes. Kellanova's Baa2 senior unsecured ratings and Prime-2 commercial paper rating remains unchanged. The outlook is stable. Kellanova will utilize the net proceeds for general...
Moody's Ratings (Moody's) today assigned an A1 rating to The Coca-Cola Company's ("Coca-Cola") new senior unsecured Euro notes. All other ratings for the company including the A1 senior unsecured and Prime-1 commercial paper ratings remain unchanged. The rating outlook remains stable. Coca-Cola pl...
Moody's Ratings (Moody's) today assigned a Baa2 rating to Kellanova's ("Kellanova") proposed $300 million of 30-year senior unsecured notes. Kellanova's Baa2 senior unsecured ratings and Prime-2 commercial paper rating remains unchanged. The outlook is maintained at stable. Kellanova will utilize ...
Moody's Ratings (Moody's) today assigned an A1 rating to The Coca-Cola Company's ("Coca-Cola") new US dollar senior unsecured notes. All other ratings for the company including the A1 senior unsecured and Prime-1 commercial paper ratings remain unchanged. The rating outlook remains stable. Coca-Co...
CORAL GABLES, Fla.--(BUSINESS WIRE)-- Fresh Del Monte Produce Inc. (NYSE: FDP) today announced that management will participate in 19th Annual BMO Global Farm to Market Conference in New York, NY on May 15-16, 2024. Monica Vicente, Senior Vice President and Chief Financial Officer, and Bianca Hernandez, Senior Manager of Investor Relations, will hold meetings with institutional investors on Wednesday, May 15 and Thursday, May 16, 2024. To schedule a meeting with management, please contact your BMO representative. If you are unable to attend the conference and would like to schedule a call wi...
Tyson Foods Reports Second Quarter 2024 Results Year-Over-Year Growth in Operating Income Highlights Progress on Strategic Initiatives SPRINGDALE, Ark., May 06, 2024 (GLOBE NEWSWIRE) -- Tyson Foods, Inc. (NYSE: TSN), one of the world’s largest food companies and a recognized leader in protein with leading brands including Tyson, Jimmy Dean, Hillshire Farm, Ball Park, Wright, Aidells, ibp and State Fair, reported the following results: (in millions, except per share data)Second Quarter Six Months Ended 2024 2023 2024 2023Sales$ 13,072 ...
>Q1 2024 earnings beat forecasts, 2024 guidance confirmed - Moderna reported yesterday during trading Q1 2024 earnings above forecasts. In brief, Q1 sales stood at $ 167m, +60% above forecasts. On the operating front, we note strong cost control justifying a net loss that was better than expected (-$ 1.2bn, 12% above forecasts). Lastly, the company’s cash position remains just as robust with $ 12.2bn at the end of March, vs $ 13.3bn at the end of last year.The ke...
>Résultats T1 24 supérieurs aux attentes et Guidance 2024 confirmée - Moderna a publié hier en journée des résultats du T1 24 supérieurs aux attentes. Brièvement, les ventes du T1 ressortent à 167 M$, +60% au-dessus des attentes. Sur le plan opérationnel, nous pouvons noter un bon contrôle des coûts justifiant une perte nette meilleure qu’attendu (-1,2 Md$ ; 12% sup. aux att). Enfin, la trésorerie de l'entreprise reste toujours aussi solide, avec 12,2 Md$ à la fin du...
Two Directors at CVS Health Corp bought 10,181 shares at between 53.879USD and 54.492USD. The significance rating of the trade was 98/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over th...
Tyson Foods To Participate in 19th Annual BMO Global Farm to Market Conference SPRINGDALE, Ark., May 02, 2024 (GLOBE NEWSWIRE) -- Tyson Foods, Inc. (NYSE: TSN) announced today that management will participate in the 19th Annual BMO Global Farm to Market Conference on May 15, 2024 in New York City. The fireside chat with Donnie King, president & CEO, and John R. Tyson, executive vice president & CFO, will begin at approximately 8:00 a.m. Eastern Time and will be available via a live webcast. The webcast link, replay, and other information can be accessed on the company’s investor relations...
Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights Approximately $750 million in cash, cash equivalents and investments at end of Q1 2024, expected to fund operations into second half of 2026 CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today reported first quarter 2024 financial results and corporate highlights. “We have started 2024 with a focus on maintaining strong exec...
CORAL GABLES, Fla.--(BUSINESS WIRE)-- Fresh Del Monte Produce Inc. (NYSE: FDP), ("Fresh Del Monte" or the "Company") today reported financial results for the first quarter ended March 29, 2024. “We are pleased with the ongoing momentum in our higher-margin fresh and value-added segment. During the first quarter of 2024, this prioritized area of our business delivered 5% revenue growth driven by our strategic initiatives around distribution, pricing, and premiumization. While service level issues and competitive market pressures in North America and Europe reduced our banana revenue, we conti...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.